These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36275363)

  • 21. Synthetic lethality between the cohesin subunits
    van der Lelij P; Lieb S; Jude J; Wutz G; Santos CP; Falkenberg K; Schlattl A; Ban J; Schwentner R; Hoffmann T; Kovar H; Real FX; Waldman T; Pearson MA; Kraut N; Peters JM; Zuber J; Petronczki M
    Elife; 2017 Jul; 6():. PubMed ID: 28691904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of long non-coding RNA TUG1 predicts poor prognosis and promotes cancer cell proliferation and migration in high-grade muscle-invasive bladder cancer.
    Iliev R; Kleinova R; Juracek J; Dolezel J; Ozanova Z; Fedorko M; Pacik D; Svoboda M; Stanik M; Slaby O
    Tumour Biol; 2016 Oct; 37(10):13385-13390. PubMed ID: 27460088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B7‑H3 promotes malignant progression of muscle‑invasive bladder cancer.
    Xu ZL; Zhang Y; Wang L; Li F; Man HW; Li PF; Shan BE
    Oncol Rep; 2018 Nov; 40(5):2722-2733. PubMed ID: 30132557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutational Landscape of Bladder Cancer in Mexican Patients:
    Pérez-Montiel MD; Cerrato-Izaguirre D; Sánchez-Pérez Y; Diaz-Chavez J; Cortés-González CC; Rubio JA; Jiménez-Ríos MA; Herrera LA; Scavuzzo A; Meneses-García A; Hernández-Martínez R; Vaca-Paniagua F; Ramírez A; Orozco A; Cantú-de-León D; Prada D
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Whole-exome sequencing of muscle-invasive bladder cancer identifies recurrent copy number variation in IPO11 and prognostic significance of importin-11 overexpression on poor survival.
    Zhao J; Xu W; He M; Zhang Z; Zeng S; Ma C; Sun Y; Xu C
    Oncotarget; 2016 Nov; 7(46):75648-75658. PubMed ID: 27689332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of TAp63γ and P53 point mutations in regulating DNA repair, mutational susceptibility and invasion of bladder cancer cells.
    Wang HT; Lee HW; Weng MW; Liu Y; Huang WC; Lepor H; Wu XR; Tang MS
    Elife; 2021 Nov; 10():. PubMed ID: 34747697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutations in STAG2 cause an X-linked cohesinopathy associated with undergrowth, developmental delay, and dysmorphia: Expanding the phenotype in males.
    Mullegama SV; Klein SD; Signer RH; ; Vilain E; Martinez-Agosto JA
    Mol Genet Genomic Med; 2019 Feb; 7(2):e00501. PubMed ID: 30447054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of Different miRNAs and Their Relevant miRNA Targeted Genes Involved in Sister Chromatid Cohesion and Segregation (SCCS)/chromatin Remodeling Pathway on T1G3 Urothelial Carcinoma (UC) Response to BCG Immunotherapy.
    Awadalla A; Zahran MH; Abol-Enein H; Zekri AN; Elbaset MA; Ahmed AE; Hamam ET; Elsawy A; Khalifa MK; Shokeir AA
    Clin Genitourin Cancer; 2022 Jun; 20(3):e181-e189. PubMed ID: 34998699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of Stag2 cooperates with EWS-FLI1 to transform murine Mesenchymal stem cells.
    El Beaino M; Liu J; Wasylishen AR; Pourebrahim R; Migut A; Bessellieu BJ; Huang K; Lin PP
    BMC Cancer; 2020 Jan; 20(1):3. PubMed ID: 31898537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A requirement for STAG2 in replication fork progression creates a targetable synthetic lethality in cohesin-mutant cancers.
    Mondal G; Stevers M; Goode B; Ashworth A; Solomon DA
    Nat Commun; 2019 Apr; 10(1):1686. PubMed ID: 30975996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of cohesin complex components STAG2 or STAG3 confers resistance to BRAF inhibition in melanoma.
    Shen CH; Kim SH; Trousil S; Frederick DT; Piris A; Yuan P; Cai L; Gu L; Li M; Lee JH; Mitra D; Fisher DE; Sullivan RJ; Flaherty KT; Zheng B
    Nat Med; 2016 Sep; 22(9):1056-61. PubMed ID: 27500726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation.
    Guo G; Sun X; Chen C; Wu S; Huang P; Li Z; Dean M; Huang Y; Jia W; Zhou Q; Tang A; Yang Z; Li X; Song P; Zhao X; Ye R; Zhang S; Lin Z; Qi M; Wan S; Xie L; Fan F; Nickerson ML; Zou X; Hu X; Xing L; Lv Z; Mei H; Gao S; Liang C; Gao Z; Lu J; Yu Y; Liu C; Li L; Fang X; Jiang Z; Yang J; Li C; Zhao X; Chen J; Zhang F; Lai Y; Lin Z; Zhou F; Chen H; Chan HC; Tsang S; Theodorescu D; Li Y; Zhang X; Wang J; Yang H; Gui Y; Wang J; Cai Z
    Nat Genet; 2013 Dec; 45(12):1459-63. PubMed ID: 24121792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative bioinformatics analysis of prognostic and differentially expressed genes in non-muscle and muscle invasive bladder cancer.
    Silva TA; Azevedo H
    J Proteomics; 2020 Oct; 229():103951. PubMed ID: 32860965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An Oncofetal Glycosaminoglycan Modification Provides Therapeutic Access to Cisplatin-resistant Bladder Cancer.
    Seiler R; Oo HZ; Tortora D; Clausen TM; Wang CK; Kumar G; Pereira MA; Ørum-Madsen MS; Agerbæk MØ; Gustavsson T; Nordmaj MA; Rich JR; Lallous N; Fazli L; Lee SS; Douglas J; Todenhöfer T; Esfandnia S; Battsogt D; Babcook JS; Al-Nakouzi N; Crabb SJ; Moskalev I; Kiss B; Davicioni E; Thalmann GN; Rennie PS; Black PC; Salanti A; Daugaard M
    Eur Urol; 2017 Jul; 72(1):142-150. PubMed ID: 28408175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genomic Features of Muscle-invasive Bladder Cancer Arising After Prostate Radiotherapy.
    Mossanen M; Carvalho FLF; Muralidhar V; Preston MA; Reardon B; Conway JR; Curran C; Freeman D; Sha S; Sonpavde G; Hirsch M; Kibel AS; Van Allen EM; Mouw KW
    Eur Urol; 2022 May; 81(5):466-473. PubMed ID: 34953602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations.
    Tirode F; Surdez D; Ma X; Parker M; Le Deley MC; Bahrami A; Zhang Z; Lapouble E; Grossetête-Lalami S; Rusch M; Reynaud S; Rio-Frio T; Hedlund E; Wu G; Chen X; Pierron G; Oberlin O; Zaidi S; Lemmon G; Gupta P; Vadodaria B; Easton J; Gut M; Ding L; Mardis ER; Wilson RK; Shurtleff S; Laurence V; Michon J; Marec-Bérard P; Gut I; Downing J; Dyer M; Zhang J; Delattre O;
    Cancer Discov; 2014 Nov; 4(11):1342-53. PubMed ID: 25223734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of Tumor Suppressor
    Daniloski Z; Smith S
    Cancer Res; 2017 Oct; 77(20):5530-5542. PubMed ID: 28819029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of prognostic biomarkers associated with stromal cell infiltration in muscle-invasive bladder cancer by bioinformatics analyses.
    Li P; Cao J; Li J; Yao Z; Han D; Ying L; Wang Z; Tian J
    Cancer Med; 2020 Oct; 9(19):7253-7267. PubMed ID: 32786144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthetic lethal interaction between the tumour suppressor STAG2 and its paralog STAG1.
    Benedetti L; Cereda M; Monteverde L; Desai N; Ciccarelli FD
    Oncotarget; 2017 Jun; 8(23):37619-37632. PubMed ID: 28430577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cohesin subunits, STAG1 and STAG2, and cohesin regulatory factor, PDS5b, in oral squamous cells carcinomas.
    França JA; Diniz MG; Bernardes VF; Costa-Silva RC; Souza RP; Gomez RS; Gomes CC
    J Oral Pathol Med; 2017 Mar; 46(3):188-193. PubMed ID: 27341316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.